NCT00307814View on ClinicalTrials.gov

A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)

PHASE2CompletedINTERVENTIONAL

Enrollment

519

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

January 31, 2004

Conditions

AnemiaChronic Renal Insufficiency

Interventions

DRUG

Epoetin Alfa

All Listed Sponsors

lead

Ortho Biotech Products, L.P.

INDUSTRY

NCT00307814 - A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) | Biotech Hunter | Biotech Hunter